Grufity logoGrufity logo

Inari Medical, Inc. Stock Research

NARI

62.45USD+1.28(+2.09%)Market Closed

Market Summary

USD62.45+1.28
Market Closed
2.09%

NARI Alerts

NARI Stock Price

NARI RSI Chart

NARI Valuation

Market Cap

3.3B

Price/Earnings (Trailing)

-114.11

Price/Sales (Trailing)

8.71

EV/EBITDA

-154.56

Price/Free Cashflow

-139.6

NARI Price/Sales (Trailing)

NARI Profitability

EBT Margin

-6.83%

Return on Equity

-7.02%

Return on Assets

-5.81%

Free Cashflow Yield

-0.72%

NARI Fundamentals

NARI Revenue

Revenue (TTM)

383.5M

Revenue Y/Y

29.5%

Revenue Q/Q

12.02%

NARI Earnings

Earnings (TTM)

-29.3M

Earnings Y/Y

-623.76%

Earnings Q/Q

42.89%

Price Action

52 Week Range

50.5095.39
(Low)(High)

Last 7 days

-4.3%

Last 30 days

8.5%

Last 90 days

-2.5%

Trailing 12 Months

-29.7%

NARI Financial Health

Current Ratio

7.53

NARI Investor Care

Shares Dilution (1Y)

7.37%

Diluted EPS (TTM)

-0.55

Peers (Alternatives to Inari Medical)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
2.5T
387.5B
7.89% -9.00%
26.24
6.44
2.44% -5.35%
2.0T
204.1B
10.90% -8.33%
30.39
10.04
10.38% -5.25%
1.3T
282.8B
15.34% -27.18%
21.72
4.6
9.78% -21.12%
995.9B
514.0B
4.86% -40.50%
-365.88
1.94
9.40% -108.16%
MID-CAP
3.4B
258.4M
-7.02% -24.34%
-11.54
13.34
24.91% -254.56%
2.3B
9.2B
-16.32% -53.16%
-6.25
0.25
51.67% -98.90%
SMALL-CAP
1.7B
1.7B
-10.56% -16.75%
14.14
1
61.79% 371.82%
1.6B
602.5M
-7.75% -62.41%
-2.78
2.67
18.18% -18.59%
1.0B
482.4M
-10.53% -34.93%
-4.33
2.08
33.15% -170.42%
1000.0M
418.9M
-15.70% -67.27%
-2.73
2.39
-9.85% -101.06%
879.9M
478.9M
-19.31% -78.37%
-0.28
1.84
-31.50% -634.70%
759.1M
50.8M
-31.98% -85.06%
-0.97
14.94
1229.98% -13.59%
746.4M
1.1B
-5.84% -42.17%
25.87
0.68
-5.82% -92.23%
214.7M
10.3M
-28.62% -74.83%
-0.77
20.92
478.23% 7.85%

Financials for Inari Medical

Income Statement (Last 12 Months)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue6.8%383,471,000358,918,000335,630,000306,339,000276,984,000
Gross Profit6.2%338,965,000319,260,000299,996,000276,238,000252,227,000
Operating Expenses8.0%367,064,000339,722,000313,387,000276,189,000241,383,000
  S&GA Expenses9.6%292,843,000267,187,000247,458,000217,199,000190,365,000
  R&D Expenses2.3%74,221,00072,535,00065,929,00058,990,00051,018,000
EBITDA-41.0%-21,218,000-15,045,000-8,826,0003,672,000-
EBITDA Margin-32.0%-0.06-0.04-0.030.01-
Earnings Before Taxes-32.9%-26,185,000-19,696,000-13,126,000-111,00010,685,000
EBT Margin-24.4%-0.07-0.05-0.040.00-
Interest Expenses-0.3%294,000295,000294,000295,000295,000
Net Income-30.9%-29,267,000-22,362,000-15,013,000-758,0009,840,000
Net Income Margin-22.5%-0.08-0.06-0.040.00-
Free Cahsflow-13.3%-23,923,000-21,111,000-16,066,000-7,505,000-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets3.3%504488484484312
  Current Assets3.0%423411411413245
    Cash Equivalents-27.9%60.0084.0080.0018793.00
  Inventory9.8%33.0030.0027.0024.0021.00
  Net PPE2.2%22.0021.0020.0018.0016.00
Liabilities19.8%87.0073.0070.0065.0072.00
  Current Liabilities32.7%56.0042.0041.0036.0043.00
Shareholder's Equity0.5%417415414419239
  Retained Earnings-14.1%-46.85-41.05-30.90-20.71-17.58
  Additional Paid-In Capital1.3%463457446440257
Accumulated Depreciation16.1%8.007.006.005.00-
Shares Outstanding0.8%54.0054.0053.0053.0050.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-36.7%-13.97-10.22-2.748.0025.00
  Share Based Compensation12.1%29.0026.0031.0028.0025.00
Cashflow From Investing-18.6%-195-164-185-102-51.02
Cashflow From Financing-0.6%1771781771784.00

Risks for NARI

What is the probability of a big loss on NARI?

88%


Probability that Inari Medical stock will be more than 20% underwater in next one year

65.3%


Probability that Inari Medical stock will be more than 30% underwater in next one year.

36%


Probability that Inari Medical stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does NARI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Inari Medical was unfortunately bought at previous high price.

Drawdowns

Returns for NARI

Cumulative Returns on NARI

Which funds bought or sold NARI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-23
MetLife Investment Management, LLC
reduced
-2.33
-589,619
3,465,800
0.03%
2023-03-17
American Portfolios Advisors
reduced
-18.08
-9,618
67,483
-%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
reduced
-77.71
-2,513,100
608,905
-%
2023-03-06
Rockefeller Capital Management L.P.
unchanged
-
-
-
-%
2023-02-28
Voya Investment Management LLC
reduced
-4.87
-544,429
2,702,570
-%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
21.78
289,000
4,707,000
0.05%
2023-02-21
MACQUARIE GROUP LTD
reduced
-28.21
-68,318,000
115,352,000
0.14%
2023-02-21
NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC
reduced
-35.6
-219,950
284,050
0.01%
2023-02-17
TRUIST FINANCIAL CORP
sold off
-100
-234,000
-
-%
2023-02-16
HARBOUR INVESTMENTS, INC.
unchanged
-
-746
15,254
-%

1–10 of 45

Latest Funds Activity

Are funds buying NARI calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own NARI
No. of Funds

Inari Medical News

MarketBeat

Bank of New York Mellon Corp Buys 103966 Shares of Inari Medical ....

MarketBeat,
16 hours ago

The Motley Fool

Value the Markets

Zacks Investment Research

Yahoo Finance

Yahoo Finance

Schedule 13G FIlings of Inari Medical

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 24, 2023
point72 asset management, l.p.
4.9%
2,611,241
SC 13G
Feb 14, 2023
macquarie group ltd
3.38%
1,814,852
SC 13G/A
Feb 14, 2023
alliancebernstein l.p.
4.1%
2,183,673
SC 13G/A
Feb 13, 2023
capital international investors
0.1%
72,099
SC 13G/A
Feb 13, 2023
milder donald b
6.0%
3,225,220
SC 13G/A
Feb 10, 2023
cvf, llc
4.8%
2,591,665
SC 13G/A
Feb 09, 2023
vanguard group inc
8.07%
4,331,429
SC 13G/A
Feb 06, 2023
wellington management group llp
9.20%
4,938,574
SC 13G/A
Jan 26, 2023
blackrock inc.
10.6%
5,671,100
SC 13G/A
Jan 20, 2023
blackrock inc.
10.6%
5,671,100
SC 13G/A

NARI Fair Value

Inari Medical fair value in different scenarios

The table shows the Fair Value estimates for Inari Medical for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

11.86

-81.01%

14.93

-76.09%

28.86

-53.79%

47.63

-23.73%

80.09

28.25%
Current Inflation

10.97

-82.43%

13.60

-78.22%

25.54

-59.10%

41.38

-33.74%

68.77

10.12%
Very High Inflation

9.89

-84.16%

11.99

-80.80%

21.63

-65.36%

34.15

-45.32%

55.78

-10.68%

Historical Inari Medical Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Inari Medical

View All Filings
Date Filed Form Type Document
Mar 21, 2023
4
Insider Trading
Mar 17, 2023
4
Insider Trading
Mar 14, 2023
4
Insider Trading
Mar 14, 2023
4
Insider Trading
Mar 14, 2023
4
Insider Trading
Mar 14, 2023
4
Insider Trading
Mar 01, 2023
4
Insider Trading
Feb 27, 2023
S-8
Employee Benefits Plan
Feb 27, 2023
8-K
Current Report
Feb 27, 2023
10-K
Annual Report

Latest Insider Trading transactions for NARI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-03-20
Hykes Andrew
sold
-578,610
64.29
-9,000
president and ceo
2023-03-15
Hoffman William
acquired
10,700
0.428
25,000
-
2023-03-15
Hoffman William
sold
-1,580,870
63.2348
-25,000
-
2023-03-14
Hoffman William
sold
-300,500
60.1
-5,000
-
2023-03-13
Hill, Mitch C.
acquired
2,970
0.457
6,500
chief financial officer
2023-03-13
Hill, Mitch C.
sold
-747,585
58.6341
-12,750
chief financial officer
2023-03-12
Hoffman William
acquired
-
-
961,350
-
2023-03-12
Tu Thomas
acquired
-
-
292,584
chief medical officer
2023-03-12
Hill, Mitch C.
acquired
-
-
125,393
chief financial officer
2023-03-12
Hykes Andrew
acquired
-
-
430,517
president and ceo

1–10 of 50

About Inari Medical

NARI Income Statement

2022-12-31
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Revenue$ 383,471$ 276,984$ 139,670
Cost of goods sold44,50624,75713,106
Gross profit338,965252,227126,564
Operating expenses   
Research and development74,22151,01818,399
Selling, general and administrative292,843190,36589,746
Total operating expenses367,064241,383108,145
(Loss) income from operations(28,099)10,84418,419
Other income (expense)   
Interest income1,852154484
Interest expense(294)(295)(1,135)
Change in fair value of warrant liabilities00(3,317)
Other income (expense)356(18)(662)
Total other income (expense)1,914(159)(4,630)
(Loss) income before income taxes(26,185)10,68513,789
Provision for income taxes3,0828450
Net (loss) income(29,267)9,84013,789
Other comprehensive income (loss)   
Foreign currency translation adjustments(592)(379)0
Unrealized gain (loss) on available-for-sale debt securities1,843(27)4
Total other comprehensive income (loss)1,251(406)4
Comprehensive (loss) income$ (28,016)$ 9,434$ 13,793
Net (loss) income per share   
Basic$ (0.55)$ 0.20$ 0.43
Diluted$ (0.55)$ 0.18$ 0.27
Weighted average common shares used to compute net (loss) income per share   
Basic52,837,67449,815,91432,033,827
Diluted52,837,67455,594,15951,554,996

NARI Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets  
Cash and cash equivalents$ 60,222$ 92,752
Short-term investments in debt securities266,17983,348
Accounts receivable, net58,61142,351
Inventories, net32,58121,053
Prepaid expenses and other current assets5,3125,694
Total current assets422,905245,198
Property and equipment, net21,65516,471
Operating lease right-of-use assets50,70344,909
Deposits and other assets8,889981
Long-term investments in debt securities03,983
Total assets504,152311,542
Current liabilities  
Accounts payable7,6596,541
Payroll-related accruals38,95524,433
Accrued expenses and other current liabilities8,24910,737
Operating lease liability, current portion1,311802
Total current liabilities56,17442,513
Operating lease liabilities, noncurrent portion30,97628,404
Other long-term liability01,416
Total liabilities87,15072,333
Commitments and contingencies (Note 7)
Stockholders' equity  
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2022 and 202100
Common stock, $0.001 par value, 300,000,000 shares authorized as of December 31, 2022 and 2021; 54,021,656 and 50,313,452 shares issued and outstanding as of December 31, 2022 and 2021, respectively5450
Additional paid in capital462,949257,144
Accumulated other comprehensive income (loss)849(402)
Accumulated deficit(46,850)(17,583)
Total stockholders' equity417,002239,209
Total liabilities and stockholders' equity$ 504,152$ 311,542